A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
Clinical trial NCT06147570 · RECRUITING
Trial details
- NCT number
- NCT06147570
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-25
- Primary completion
- 2027-08-31
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.